验证的草本提取物用于缓解化疗诱导的骨髓抑制:系统性审查和元分析
De-Hui Wang1, Xiao-Ni Ma1, Yan Wang1
1School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
概括
植物提取物显示出对化疗诱导的骨髓抑制有显著的保护作用. 这些天然药物可以增加血液细胞数量并增强免疫力,为减轻这种严重的副作用提供了一个有希望的方法.
科学领域:
- 综合性瘤学是一种综合性瘤学.
- 药理学 药理学是指药理学的学科.
- 血液学 血液学 血液学
背景情况:
- 化疗诱导的骨髓抑制是一种关键的剂量限制毒性,影响骨髓功能,免疫力,并导致出血.
- 严重的骨髓抑制可能需要停止治疗,从而对患者的治疗结果产生负面影响.
- 缓解骨髓抑制的药物对于优化癌症治疗至关重要.
研究的目的:
- 系统地评估草本提取物对抗化疗诱导的骨髓抑制的疗效.
- 提供关于草药在临床环境中管理骨髓抑制的潜力的证据.
- 探索草本提取物在支持性癌症治疗中的未来临床应用.
主要方法:
- 来自英语和中文数据库的95项实验研究的系统审查和元分析.
- 纳入标准侧重于动物研究,评估草本提取物对骨髓抑制的影响与对照组.
- 数据的提取和分析以关键的骨髓抑制相关结果为中心.
主要成果:
- 草本提取物显示出对肌肉骨抑制有显著的保护作用.
- 用草药提取物治疗导致血红蛋白,白细胞,血小板和粒细胞的水平增加.
- 观察到增强的免疫功能,这表明综合益处.
结论:
- 草本提取物在缓解化疗诱导的骨髓抑制方面发挥着重要作用.
- 这些发现为进一步的临床研究和草药治疗的应用奠定了基础.
- 草药为接受化疗的癌症患者提供了有希望的支持性护理途径.
更多相关视频
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
190
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
190
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
141
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
141
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
152
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
152
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
188
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
188
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K


